Abstract:Objectives: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease that is caused by the SFTS virus (SFTSV) and has a high fatality rate. SFTSV-specific antibody profiles among patients with different clinical outcomes are yet to be described. The nucleocapsid protein (NP) is the most immunogenic viral antigen of the SFTSV. This study, therefore, sought to determine NP-specific antibody responses among SFTS patients with different disease progressions. Methods: In the present study, 43 patients with confirmed SFTS were enrolled in our cohort, and 9 of them deceased. The clinical presentations and key laboratory parameters associated with SFTS fatality were also recorded. Serum samples from each patient were collected every 2 days during their hospitalization. NP-specific IgM and IgG responses as well as Gn or Gc-specific IgM responses were examined by enzyme-linked immunosorbent assay (ELISA), whereas, the dynamic viral loads of SFTSV RNA were quantified via real-time reverse transcription polymerase chain reaction (RT-PCR). Results: First, 77% of patients generated positive NP-specific IgM antibody responses within two weeks since illness onset, defined as 'N-specific IgM-positive patients', while the rest of the patients were termed as 'N-specific IgM-delayed patients'. Only 17% of the patients generated NP-specific IgG responses. The absence of NPspecific humoral responses was strongly associated with a high risk of fatality and severity of SFTS. IgM-positive patients had significantly lower levels of viral loads, less disturbed coagulopathy, and hepatic and cardiac damage compared to IgM-delayed patients. Moreover, compared to severe or fatal SFTS patients, mild SFTS patients had significantly higher magnitudes of NP-specific IgM responses, but not NP-specific IgG, Gn-specific IgM, or Gc-specific IgM responses. The abundance of NP-specific IgM responses negatively correlated with viral loads, coagulation disturbances, and hepatic injuries among SFTS patients. Conclusions: Our data highlight distinct humoral profiles of NP-specific IgM responses among SFTS patients with different disease progressions and clinical outcomes.

Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection

The clinical and immunological characteristics in fatal severe fever with thrombocytopenia syndrome virus (SFTSV) infection

Single-cell landscape of peripheral immune responses to fatal SFTS

Downregulation of Interferon-β and Inhibition of TLR3 Expression are associated with Fatal Outcome of Severe Fever with Thrombocytopenia Syndrome

Correlations between clinical features and death in patients with severe fever with thrombocytopenia syndrome.

Concurrent Measurement of Dynamic Changes in Viral Load, Serum Enzymes, T Cell Subsets, and Cytokines in Patients with Severe Fever with Thrombocytopenia Syndrome

Clinical Characteristics and Immune Status of Patients with Severe Fever with Thrombocytopenia Syndrome.

SFTSV infection is associated with transient overproliferation of monoclonal lambda-type plasma cells

Serum lipidome reveals lipid metabolic dysregulation in severe fever with thrombocytopenia syndrome

Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome

Nucleocapsid Protein-Specific IgM Antibody Responses in the Disease Progression of Severe Fever with Thrombocytopenia Syndrome

Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus

Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (Review)

Multiple Organ Involvement in Severe Fever with Thrombocytopenia Syndrome: an Immunohistochemical Finding in a Fatal Case

Clinical Progress and Risk Factors for Death in Severe Fever with Thrombocytopenia Syndrome Patients.

Severe fever with thrombocytopenia syndrome virus replicates in platelets and enhances platelet activation.

SFTSV Infection Induces BAK/BAX-Dependent Mitochondrial DNA Release to Trigger NLRP3 Inflammasome Activation.

Severe fever with thrombocytopenia syndrome virus induces platelet activation and apoptosis via a reactive oxygen species-dependent pathway

Architecture of Severe Fever with Thrombocytopenia Syndrome Virus

Severe Fever with Thrombocytopenia Syndrome Bunyavirus-Related Human Encephalitis

Cytokines and lymphocyte subsets are associated with disease severity of severe fever with thrombocytopenia syndrome